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Abstract
 .Primary hyperparathyroidism HPT is associated with generalized skeletal changes, its full-blown osseous manifestations known as
 .osteitis fibrosa cystica. Fibrous dysplasia FD , a benign bone disorder, is differentiated from generalized fibrocystic disease caused by
hyperparathyroidism. The classic triad of McCune–Albright syndrome includes polyostotic FD, patchy skin pigmentation, and sexual
precocity. Other associated endocrinopathies are hyperthyroidism, Cushing’s syndrome, acromegaly, and HPT. We describe a patient with
severe generalized and focal bone lesions and sexual precocity. HPT was diagnosed and treated with persistence of cystic bone lesions.
The similarities between HPT and FD are discussed, focusing on a possible genetically determined mechanism to explain the relationship
between them. q 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
 .Primary hyperparathyroidism HPT has long been as-
sociated with generalized skeletal changes. The initial
lesions show merely a decrease in bone density. In time,
they may become very extensive and lead to deformities
and fractures. The full-blown osseous manifestations of
HPT have been traditionally known as osteitis fibrosa
 . w xcystica OFC or Recklinghausen’s disease 1 .
Primary HPT is now recognized as a common and often
symptomless endocrine disorder with an estimated preva-
w xlence of 100 cases per 100 000 normal population 2–4 .
The disorder is most common in the fifth and sixth decades
w xand is two or three times more common in women 2,3 . It
seems apparent that the availability of accurate and inex-
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pensive instruments to measure serum calcium is at least
partly responsible for the rapid increase in the diagnosis of
w xHPT 4 . A solitary parathyroid adenoma is the underlying
w xpathology in more than 80% of cases 2,3 .
 .Fibrous dysplasia FD , a benign bone disorder charac-
terized by extensive proliferation of fibrous tissue, differ-
entiated from generalized fibrocystic bone disease caused
by hyperfunction of parathyroid glands by Hunter and
w xTurbull in 1930 1,5 . In 1937, Albright described the
association of FD with various endocrinological and skele-
tal abnormalities as well as with cutaneous pigmentation
w x6 . The classic triad of McCune–Albright syndrome
includes polyostotic FD, patchy skin pigmentation, and
sexual precocity. Other associated endocrinopathies are
hyperthyroidism, Cushing’s syndrome, acromegaly, hyper-
w xprolactinemia, and HPT 6,7 . FD comprises 2.5% of all
bone neoplasms and 7% of all benign bone tumors. The
incidence of McCune–Albright syndrome is much less
than the usual forms of FD, with a ratio of 1 is to 30 or
w x40 5 .
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Fig. 1. X-ray of femurs showing diffuse osteoporosis, with cancellous bone hyperdensity and cortical hypodensity.
We describe a patient with severe generalized bone
disease, focal osteolytic lesions, and sexual precocity asso-
ciated with hyperestrogenism, in which HPT was diag-
nosed.
2. Case report
A 63-year-old Caucasian woman was admitted to the
hospital with a 2-month history of intense fatigue, weight
 .loss 4 kg and bone pain, most prominent in the knees.
She had had pulmonary tuberculosis at age 8, and she had
also suffered from a ‘bone disease’ during childhood. Her
gynaecological history included menarche at age 9, one
pregnancy with a term delivery, and menopause at age 46.
She did not receive hormonal replacement therapy. There
was no family history of endocrinopathies or bone disease.
Physical examination revealed no abnormalities except
pallor.
Laboratory results showed the presence of anemia: red
 . 3  .blood cells RBC 2 750 000 cellsrmm , hemoglobin Hb
 .7.8 grdl, hematocrit Ht 23.6%, median globular volume
 .  .MGV 85.8 fl; erythrocyte sedimentation rate ESR 70
 .Fig. 2. Osteolytic expansile lesions in distal right femur and proximal left tibia arrows .
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Fig. 3. CT scan of right femur revealing a soft tissue mass.
 .mmrh; urea 88 mgrdl 14.7 mmolrl , creatinine 1.6
 .  .mgrdl 145 mmolrl , uric acid 9 mgrdl 535 mmolrl ,
Na 145 mmolrl, K 4.1 mmolrl, Cl 116 mmolrl, Cas s s s
 .  .15.2 mgrdl 3.8 mmolrl , P 2.5 mgrdl 0.8 mmolrl ,s
alkaline phosphatase 757 Url. Serum and urinary immu-
noelectrophoresis revealed a normal pattern. All other
biochemical results were within normal limits, as were
measurements of immunoglobulins and tumoral markers.
Skeletal radiographs revealed severe diffuse osteoporosis,
with cancellous bone hyperdensity and cortical bone hypo-
Fig. 4. Photomicrograph of the osteomedullar biopsy showing localized osteoclastic resorption of bone tissue and fibrosis of the marrow Trichrome
.Masson stain, 100= .
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 .density Fig. 1 , multiple osteolytic expansile lesions, some
of which were causing rupture of cortical bone, most
prominent in the distal right femur and in the proximal left
 .tibia Fig. 2 . A radionuclide bone scan demonstrated
increased uptake in the entire skeleton, most prominent in
the extremities. The patient was treated with saline, furo-
semide, hydrocortisone, indomethacin, and pamidronate
 .45 mgr24 h, i.v. to control hypercalcemia. During her
stay in the hospital, she suffered pathological fracture of
 .both femoral necks. A computed tomographic CT scan
revealed a soft-tissue mass within the diametaphyseal re-
gion of the distal right femur, with disruption and destruc-
tion of the cortex, and smaller lesions bilaterally in the
 .proximal femurs Fig. 3 .
 .Serum intact parathyroid hormone PTH was 18 ngrml
 .  .N-1.9 ; FSH 17.1 mUrml N: 20–138 , LH 2.6 mUrml
 .  .N: 15–62 , plasmatic 17b-estradiol 40 pgrml N: 10–35 ,
considering postmenopausal normal values. The levels of
prolactin, T , T , TSH, cortisol, and testosterone were3 4
normal.
Osteomedullar biopsy of the iliac crest and biopsy of
the osteolytic lesion in the proximal left tibia disclosed
extensive fibrosis with replacement of bone marrow by
 .connective tissue Fig. 4 . Ultrasonography of thyroid and
 .pelvis were normal. A magnetic resonance imaging MRI
study revealed a mediastinal, pretracheal mass with a
diameter of 3.5 cm. The inferior right parathyroidectomy
revealed a chief cell adenoma of the parathyroid gland.
After surgery, there was a period of 2 weeks of
hypocalcemia, consistent with a ‘hungry bone’ syndrome,
which was treated. There was normalization of the levels
of calcium and PTH under therapy with a bisphosphonate,
calcium, and vitamin D. Hemoglobin levels and renal
function returned to normal. The progressive remineraliza-
tion of bones made it possible to implant a bilateral
femoral prosthesis. Nevertheless, the radiological follow-up
performed 1 year later demonstrated that the cystic femoral
and tibial lesions remained unchanged.
3. Discussion
HPT and malignant disorders account for more than
w x90% of cases of hypercalcemia 2,3 . The initial diagnostic
possibility in this patient was primary HPT, which is
consistent with the hypercalcemia, the borderline-low
serum phosphorus level, and the substantial increase in the
chloride–phosphorus ratio, which was 46. Given the pres-
ence of anemia and an elevated ESR, another important
consideration in the initial differential diagnosis is an
occult neoplasm, such as myeloma or a malignant tumour,
with bone metastization or with a paraneoplastic hyper-
w xcalcemia due to production of a PTH-like polypeptide 3 .
The finding of diffuse bone changes, in addition to the
osteolytic focal lesions, points to a metabolic bone disease.
In this case, the measurement of the level of intact PTH,
which is approximately 10 times the upper limit of normal,
is consistent with the diagnosis of HPT.
In contemporary practice, bone disease on presentation
w xis seen in only 5% of patients with primary HPT 8 . Thus,
OFC, the classic bone disease of HPT, is rarely seen today.
Locally destructive lesions, such as bone cysts and ‘brown
tumors’, occur only in more advanced stages of hyper-
w xparathyroid bone disease 2,3 . They may present radiolog-
ically as expansile, multilocular masses, with alternation of
w xsolid and cystic areas 9 .
Primary HPT mainly affects cortical bone with sparing
of the cancellous bone. It causes demineralization, in-
creased osteoclastic activity with resorption of bone and
peritrabecular fibrosis, and marrow fibrosis with the forma-
tion of micro- to macrocysts within the enlarged fibrotic
w xmarrow spaces 9 . The brown tumors show clusters of
hemosiderin-laden macrophages and large, multinucleated
w xgiant cells within blood vessels 8 . In OFC, the amount of
w xfibrosis appears related to the severity of the disease 8 .
Nowadays, as patients with HPT usually present at an
early stage of the disease, the presence of important focal
lesions, as demonstrated in our patient, should alert one to
the possibility of an unrelated bone disease. In our case,
bone examination revealed intense fibrosis, as seen in FD
w x5,9 , instead of the typical histological features of a brown
w xtumor 3 . The extensive replacement of bone marrow by
fibrous tissue explains the presence of anemia and its
recovery after parathyroidectomy.
In FD with multiple bone lesions, the lower extremities
w xand pelvis are most affected often 5 , and it is associated
with spontaneous fractures of the femoral neck, as in our
case, and deformity, depending on the extent of disease, as
w xwell as malignant transformation 8,9 . The radiological
appearance of the lesions of the face and skull are pre-
dominantly osteosclerotic, whereas those in other areas
show more trabeculation, with thinning of the cortex and
w xformation of cyst-like lesions 5 . The cystic form of FD
w xmay be confused with the radiological signs of HPT 5,7 .
Considering that HPT has been found to be associated
with other primary endocrinopathies and the patient’s past
history of bone disease in childhood and precocious pu-
berty, it was decided to measure the levels of other hor-
mones. A pattern of estrogens and gonadotrophins was
found that was not consistent with the postmenopausal
state of the patient, with an apparent primary hyperestro-
genism, although no ovarian masses were disclosed on
ultrasonography. Consequently, we could consider the pos-
sibility of microscopic ovarian cysts as the cause of in-
creased levels of estrogens.
Although this patient did not present the classical triad
of McCune–Albright syndrome, it is possible that the HPT
was not a solitary endocrinopathy but that it was associ-
w xated with FD and other endocrinological disorders 5 .
Except for the McCune–Albright syndrome, concomitance
of HPT and FD had been reported in a few patients before,
and it has been suggested that this may represent a variant
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w xof McCune–Albright syndrome 7,8 . There is also an
apparent histological similarity between OFC, FD, and
nonossifying fibroma, and some authors look upon FD as a
w xvariant of nonossifying fibroma 8 . Therefore, there may
be a basis for viewing the combination of primary HPT
and fibro-osseous lesions of bone as yet another example
w xof a clinical endocrine syndrome 8 .
Recently, a theory was formulated trying to explain the
mechanisms subjacent to these disorders. First, sexual
precocity in McCune–Albright syndrome, more accurately
termed ‘pseudoprecocious puberty’, is generally accepted
not to be mediated via maturation of the hypothalamic–
pituitary–ovarian axis, and many of these patients have
been found to have autonomously functioning follicular
cysts. Second, the other endocrinopathies of this syndrome
are likewise thought to be due to autonomously function-
w xing nodular disease 6 . Thus, the most widely accepted
hypothesis of the pathophysiology of the disorder has been
that multiple, discrete areas of autonomously functioning
cells arise in various tissues that harbor embryologically
dysfunctional clones of cells. Currently, defective signal
transduction for glycoprotein hormones with a G-protein
chronically ‘turned on’ is thought to be the central feature
w xof the disorder 6 . Thus, all tumors associated with Mc-
Cune–Albright syndrome have one thing in common: they
arise from cells that are usually under control, in what
concerns its secretion and proliferation, of a hormone
acting on a receptor coupled with G protein, a member ofs
the G-protein family. This may explain why polyostotic
FD lesions are sometimes quite similar to the cystic bone
lesions observed in HPT, which is due to the hypersecre-
tion of PTH, also a hormone whose receptor is coupled to
w xG protein 10 .s
It may be concluded that the possible relationship be-
tween HPT and FD arises from the fact that both diseases
may cause similar radiological and histological changes in
bones and that HPT has been found to be associated with
McCune–Albright syndrome in some patients. Cystic le-
w xsions of HPT may continue indefinitely 9 , but they
usually become filled with bone and sclerotic tissue, con-
w xsistent with a healing brown tumor 3 . Follow-up of the
changes in bone disease after parathyroidectomy can help
w xone to reach a clear-cut diagnosis 7 . In our patient, the
cystic lesions persisted unchanged months after parathy-
roidectomy, which made us consider the possibility of FD.
We admit the bone disease was multifactorial in view of
the patient’s primary HPT, the osteoporosis related to her
w xpostmenopausal state, and the polyostotic FD 6 . We also
feel that it could also be a consequence of a more complex
disease involving a mutation of the gene of a G-protein,
which is responsible for endocrinological disorders charac-
terized by the autonomous secretion of hormones.
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